Krizia Sanna
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis.
Journal: Frontiers in molecular neuroscience
Published: May 09, 2024
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis.
Journal: Frontiers in immunology
Published: April 11, 2024
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis.
Journal: Journal of neuroinflammation
Published: February 09, 2024
Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis.
Journal: Neuropharmacology
Published: December 06, 2023
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis.
Journal: Current neuropharmacology
Published: November 16, 2022
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis.
Journal: Neurobiology of disease
Published: March 28, 2022
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis.
Journal: Neuropathology and applied neurobiology
Published: February 15, 2021
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis.
Journal: Brain, behavior, and immunity
Published: February 15, 2021
Corrigendum: Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis.
Journal: Frontiers in cellular neuroscience
Published: December 29, 2020
Re-Examining the Role of TNF in MS Pathogenesis and Therapy.
Journal: Cells
Published: September 21, 2020
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis.
Journal: International journal of molecular sciences
Published: August 30, 2020
Last Updated: 09/26/2026